Codelivery of Docetaxel and Dexamethasone from Microcapsules Based on Dimorphandra mollis Galactomannan and Syagrus coronata Oil Nanoemulsion

Docetaxel (DTX) is a chemotherapeutic agent widely used in the treatment of solid tumors; however, its clinical application is limited by poor aqueous solubility, rapid systemic distribution, and dose-dependent toxicity. Dexamethasone (DEX) is commonly coadministered to reduce adverse effects associated with taxane-based therapies. In this study, a polysaccharide-based codelivery system was proposed to improve the controlled release and therapeutic performance of both drugs. Microcapsules were developed using the spray-drying technique, employing galactomannan extracted from Dimorphandra mollis as the polymeric matrix and incorporating an oil-in-water nanoemulsion based on Syagrus coronata oil loaded with both drugs. The systems were characterized in terms of structural morphology, thermal properties, encapsulation efficiency, in vitro cytotoxicity, and release profile. The results demonstrated the formation of amorphization within the polymeric matrix, as well as the formation of spherical microcapsules containing the drug-loaded nanoemulsion, with an average size of 2.57 ± 0.92 μm. High encapsulation efficiency was observed for DEX (96.19 ± 1.78%), whereas DTX showed moderate retention (52.15 ± 1.08%) after microencapsulation. In vitro release studies indicated a diffusion-controlled release mechanism. Cytotoxicity assays revealed that both the free drugs and the encapsulated system showed cytotoxic activity against HCT-116 colorectal carcinoma cells, whereas no cytotoxicity was observed for the encapsulated system in the L929 cell line. Overall, the system developed represents a promising strategy for the simultaneous delivery of different drugs.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2026-11-19
DOI
https://doi.org/10.1021/acsomega.6c07759
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Codelivery of Docetaxel and Dexamethasone from Microcapsules Based on Dimorphandra mollis Galactomannan and Syagrus coronata Oil Nanoemulsion

Anderson Freitas de Sousa, Francisco Alessandro Marinho Rodrigues, Pedro M. S. Costa, Cláudia Pessoa et al.
ACS Omega
Advanced Drug Delivery Systems
article

Codelivery of Docetaxel and Dexamethasone from Microcapsules Based on Dimorphandra mollis Galactomannan and Syagrus coronata Oil Nanoemulsion

Anderson Freitas de Sousa, Francisco Alessandro Marinho Rodrigues, Pedro M. S. Costa, Cláudia Pessoa, Nágila Maria Pontes Silva Ricardo, Facundo Álvarez Lemos, Francisco Leonardo Moreno Martins
article en

Abstract

Docetaxel (DTX) is a chemotherapeutic agent widely used in the treatment of solid tumors; however, its clinical application is limited by poor aqueous solubility, rapid systemic distribution, and dose-dependent toxicity. Dexamethasone (DEX) is commonly coadministered to reduce adverse effects associated with taxane-based therapies. In this study, a polysaccharide-based codelivery system was proposed to improve the controlled release and therapeutic performance of both drugs. Microcapsules were developed using the spray-drying technique, employing galactomannan extracted from Dimorphandra mollis as the polymeric matrix and incorporating an oil-in-water nanoemulsion based on Syagrus coronata oil loaded with both drugs. The systems were characterized in terms of structural morphology, thermal properties, encapsulation efficiency, in vitro cytotoxicity, and release profile. The results demonstrated the formation of amorphization within the polymeric matrix, as well as the formation of spherical microcapsules containing the drug-loaded nanoemulsion, with an average size of 2.57 ± 0.92 μm. High encapsulation efficiency was observed for DEX (96.19 ± 1.78%), whereas DTX showed moderate retention (52.15 ± 1.08%) after microencapsulation. In vitro release studies indicated a diffusion-controlled release mechanism. Cytotoxicity assays revealed that both the free drugs and the encapsulated system showed cytotoxic activity against HCT-116 colorectal carcinoma cells, whereas no cytotoxicity was observed for the encapsulated system in the L929 cell line. Overall, the system developed represents a promising strategy for the simultaneous delivery of different drugs.

ACS Omega
Universidade Federal do Ceará (BR)
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon